In an adult patient on aspirin for cardiovascular protection scheduled for elective lumbar fusion, how should aspirin be managed perioperatively?

Management of Aspirin in Lumbar Fusion Surgery

For patients on aspirin undergoing elective lumbar fusion, aspirin should be discontinued 7–10 days before surgery to minimize bleeding complications, then resumed within 24 hours postoperatively once hemostasis is adequate. 1, 2, 3

Preoperative Discontinuation Strategy

Standard Recommendation for Lumbar Fusion

• Stop aspirin 7–10 days before lumbar fusion surgery to allow complete platelet turnover and restore hemostatic function. 2, 3, 4
• Lumbar fusion is classified as a high bleeding-risk procedure due to the epidural venous plexus, extensive muscle dissection, and the catastrophic consequences of epidural hematoma (potential paralysis). 1, 2
• Discontinuing aspirin only 3–7 days preoperatively results in significantly increased intraoperative blood loss, postoperative drainage volume, and prolonged drain duration compared to stopping ≥7 days before surgery. 5, 4

Evidence Supporting 7–10 Day Window

• A 2013 retrospective study of 182 lumbar fusion cases demonstrated that patients who stopped aspirin 3–7 days preoperatively had significantly greater blood loss and drainage than controls, whereas those who stopped ≥7 days preoperatively showed no difference from non-aspirin users. 4
• A 2014 study of 106 lumbar fusion patients found that aspirin significantly increases bleeding risk even when discontinued 1 week prior to surgery, though the risk is lower than continuing aspirin through surgery. 5
• Platelet regeneration requires 7–10 days in most patients, and this interval can be longer in elderly patients. 2

Critical Exception: High Cardiovascular Risk Patients

When Aspirin Continuation May Be Necessary

If the patient has any of the following high-risk conditions, aspirin should NOT be stopped without cardiology consultation: 6, 1

• Coronary stent placed <12 months ago (especially drug-eluting stents <6 months or bare-metal stents <6 weeks)
• Recent myocardial infarction (<6 months)
• Recent stroke or TIA (<6 months)
• Left main coronary artery stenting
• Multiple coronary stents or complex lesions

Management Algorithm for High-Risk Patients

1. Postpone elective lumbar fusion until the patient is beyond the high-risk stent window (ideally >12 months post-stent). 1
2. If surgery cannot be delayed, continue aspirin throughout the perioperative period and accept increased bleeding risk, as stent thrombosis carries ~10% mortality risk that exceeds surgical bleeding risk. 1, 7
3. Mandatory multidisciplinary consultation with cardiology and anesthesia to weigh thrombotic versus bleeding risks. 6, 1
4. Never discontinue both aspirin and a P2Y12 inhibitor simultaneously in patients with recent stents—this dramatically increases stent thrombosis mortality. 1, 7

Postoperative Resumption

• Resume aspirin within 24 hours after surgery once adequate hemostasis is confirmed and surgical drains show acceptable output. 1, 8
• Early resumption (same-day or next-day) is acceptable when bleeding risk is low. 1
• In high-risk cardiovascular patients, aspirin should be restarted as soon as possible—ideally within 24 hours—to minimize thrombotic complications. 6, 1

Regional Anesthesia Considerations

• Aspirin monotherapy is NOT a contraindication to neuraxial (spinal/epidural) anesthesia for lumbar fusion. 6, 1, 8
• If the patient is on dual antiplatelet therapy (aspirin + clopidogrel), clopidogrel must be stopped 5 days before neuraxial anesthesia, but aspirin may be continued. 6, 1, 8
• Deep peripheral nerve blocks (e.g., posterior lumbar plexus block) should only be performed on aspirin monotherapy or after appropriate P2Y12 inhibitor discontinuation, using ultrasound guidance by experienced operators. 6

Common Pitfalls and How to Avoid Them

Pitfall 1: Stopping Aspirin Too Close to Surgery

• Discontinuing aspirin only 3–7 days preoperatively leaves residual platelet inhibition and increases bleeding complications. 5, 4
• Solution: Enforce a strict 7–10 day discontinuation interval for elective cases. 2, 3, 4

Pitfall 2: Stopping Aspirin in High-Risk Cardiovascular Patients

• Discontinuing aspirin in patients with recent coronary stents or acute coronary syndrome can precipitate fatal stent thrombosis or myocardial infarction. 6, 1
• Solution: Screen all patients for coronary stent history and recent cardiovascular events; obtain cardiology clearance before stopping aspirin in these patients. 1, 7

Pitfall 3: Combining Aspirin with NSAIDs Perioperatively

• Concurrent NSAID use increases surgical blood loss 2–3 fold when combined with aspirin. 1, 5
• Solution: Discontinue all NSAIDs for appropriate intervals (1–10 days depending on the specific NSAID) before surgery. 3

Pitfall 4: Using Heparin or LMWH as "Bridging" Therapy

• Anticoagulants do not substitute for antiplatelet therapy and increase bleeding without preventing arterial or stent thrombosis. 6, 1, 7
• Solution: Do not bridge aspirin with heparin or enoxaparin; if aspirin must be stopped, accept the gap or continue aspirin. 1

Practical Decision Algorithm

Step 1: Assess cardiovascular risk

• Review stent history, recent MI/stroke, and indication for aspirin. 1

Step 2: Low-risk patients (primary prevention or remote cardiovascular history)

• Stop aspirin 7–10 days before lumbar fusion. 2, 3, 4
• Resume within 24 hours postoperatively. 1, 8

Step 3: High-risk patients (recent stent, MI, or stroke)

• Obtain cardiology consultation. 1
• Consider postponing surgery until beyond high-risk window. 1
• If surgery cannot be delayed, continue aspirin and prepare for increased bleeding (cell saver, transfusion availability). 1, 2

Step 4: Verify NSAID discontinuation

• Ensure all NSAIDs stopped for appropriate intervals (1–10 days). 3

Step 5: Plan anesthesia

• Aspirin alone does not contraindicate neuraxial anesthesia. 6, 1
• If on dual antiplatelet therapy, stop P2Y12 inhibitor 5 days before neuraxial block. 6, 1, 8

Spine Surgery-Specific Consensus

A 2023 Delphi consensus of 20 spine surgeons recommended stopping aspirin 7 days before elective spine surgery and restarting postoperatively based on bleeding risk stratification (low-risk POD7, medium-risk POD5, high-risk POD2). 9 However, this consensus conflicts with spine-specific research showing that 7–10 days is safer for lumbar fusion specifically. 2, 4 Given the catastrophic consequences of epidural hematoma in lumbar fusion, the 7–10 day discontinuation interval is the more conservative and defensible approach. 2